An exciting observation in both in vitro studies and our human MM xenograft model of inflammation was that levels of interleukins and VEGF were blocked using the IL-1r antagonist, Anakinra, currently used for clinical treatment of various inflammatory diseases, including Muckle-Wells syndrome [37], gout [38], and arthritis [39]. This evidence concerns the gene IL1R1 and Muckle-Wells syndrome.